Objective: Overdiagnosis and overtreatment of microfocal nonpalpable and early-stage prostatic adenocarcinoma are currently a topic of strong discussion. We tried to find morphological findings of such insignificant carcinomas of the prostate.
Study Design: More than 1,000 consecutive core needle biopsy specimens of prostate carcinoma taken during 1 year (2007) were graded according to the modified Gleason scoring system. The results were correlated to serum prostate-specific antigen (PSA) and tumor extent in the cores.
Results: Cases with PSA <10 ng/ml and tumor extent <20% frequently (up to 55%) had Gleason scores of 6 or 7a. Cases with PSA >10 ng/ml or tumor extent >20% had higher Gleason scores (>7a). Cancers with tumor infiltration of <1 mm in one of up to 12 cores and PSA <10 ng/ml mainly had low Gleason scores (6 and 7a), but only 5% of the carcinomas in the studied specimens corresponded to such a parameter. Only 25% of such patients had a pT2a tumor after radical prostatectomy.
Conclusion: With a very restricted parameter of a microfocal adenocarcinoma of the prostate with a Gleason score <7a, tumor infiltration of
Download full-text PDF
Source
http://dx.doi.org/10.1007/s00120-008-1867-2 DOI Listing Publication Analysis
Top Keywords
Soc Sci Med
December 2024
Division of Infectious Diseases and Global Public Health, School of Medicine, University of California, San Diego, 9500 Gilman Drive, MC 0507, La Jolla, CA, 92093, United States. Electronic address:
The lack of socio-behavioral research on stress and psychosocial experiences among research participants who undergo analytical treatment interruption (ATI) in HIV cure studies underscores a critical gap in cure science. Existing literature acknowledges mixed and potentially adverse mental health impacts of ATIs among trial participants, but empirical insights before, during, and after clinical studies are scarce. We used longitudinal in-depth interviews with 11 participants in HIV cure-related research to explore their experiences with stress, coping, and psychological well-being before, during, and after an ATI.
View Article and Find Full Text PDFJ Family Med Prim Care
November 2024
Department of Physiology, Sheikh Bhikhari Medical College, Hazaribag, Jharkhand, India.
Introduction: Anti-thyroid antibodies not only cause thyroid dysfunction but have independent adverse outcomes in the fetus and mother during pregnancy and after birth. Chronic lymphocytic thyroiditis as a presentation of immune system deregulation may be associated with a generalized activation of the immune system at the fetus-maternal unit, the placenta. This interference could be associated with pregnancy morbidities in m o t h e r a n d fetus.
View Article and Find Full Text PDFClin Ophthalmol
November 2024
Department of Optometry and Vision Science, Hadassah Academic College, Jerusalem, Israel.
Purpose: Fusional vergence ranges (FVR) quantify the oculomotor system's ability to overcome heterophoria, playing a critical role in diagnosis and treatment. This study investigated the effect of prism order on near vertical FVR using the smooth and step methods.
Methods: Normal participants were randomly assigned to either the smooth or step testing method and to Base-Up (BU, infravergence) first or Base Down (BD, supravergence) first prism type.
Microb Pathog
January 2025
Department of Chemical and Biological Sciences, Institute of Biosciences, São Paulo State University, Botucatu, SP, 18618-691, Brazil. Electronic address:
Staphylococcus aureus enterotoxins (SEs) can lead to food poisoning and appear to play a pivotal role in the development and severity of mastitis. This study aimed to evaluate whether the presence and diversity of S. aureus Enterotoxin genes mastitis-causing are associated with the development and severity of mastitis in dairy cows.
View Article and Find Full Text PDFSurg Endosc
December 2024
Brown University General Surgery Program and The Miriam Hospital, 593 Eddy Street, Providence, RI, 02903, USA.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!